Continuous Glucose Monitoring

Education for Managed Care, Pharmacy, and Payer Professionals

Continuous Glucose Monitoring in Critically Ill Patients With COVID-19: Results of an Emergent Pilot Study


Key Takeaway: During the COVID-19 pandemic, continuous glucose monitoring is feasible in critically ill patients and has acceptable accuracy to identify trends and guide intermittent blood glucose monitoring with insulin therapy.